A multicenter, randomized phase III study comparing a 13.5 mg levonorgestrel intrauterine contraceptive system with a combined oral contraceptive: analysis of user satisfaction and safety

  • L. Borgatta, K. Roth, S. Rybowski, K. Rosen
  • Fertility and Sterility, September 2014, Elsevier
  • DOI: 10.1016/j.fertnstert.2014.07.048

The authors haven't yet claimed this publication.

Read Publication